Skip to main content

Lubner David Charles

In the past year, 1 open-market purchase filing worth $1.00M and 1 sale filing worth $450.0K.

Current role at each company

Show 3 more companies

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$1.00M
1 filing
Sold
$450.0K
1 filing
Net
+$550.0K
Bought minus sold
Companies
2
With open-market trades

Trades

Every Form 4 that lists Lubner David Charles as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

BRVE Braveheart Bio, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 7, 2026 (view filing)4:30 PM ETAug 7Same dayLubner David CharlesDirectorPPurchase+55.6K$18.00+$1.00MNew position55.6K after

ACLX Arcellx, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 20, 2026 (view filing)Jan 20Same dayLubner David CharlesDirectorSSale−6.00K$75.00−$450.0K−21.7%21.7K after10b5-1

PNT POINT Biopharma Global Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 28, 2022 (view filing)Nov 235 daysLubner David CharlesDirectorPPurchase+3.60K$6.85+$24.7KNew position3.60K after